Mercury Study Report to Congress
Total Page:16
File Type:pdf, Size:1020Kb
United States EPA-452/R-97-007 Environmental Protection December 1997 Agency Air Mercury Study Report to Congress Volume V: Health Effects of Mercury and Mercury Compounds Office of Air Quality Planning & Standards and Office of Research and Development c7o032-1-1 MERCURY STUDY REPORT TO CONGRESS VOLUME V: HEALTH EFFECTS OF MERCURY AND MERCURY COMPOUNDS December 1997 Office of Air Quality Planning and Standards and Office of Research and Development U.S. Environmental Protection Agency TABLE OF CONTENTS Page U.S. EPA AUTHORS ............................................................... iv SCIENTIFIC PEER REVIEWERS ...................................................... v WORK GROUP AND U.S. EPA/ORD REVIEWERS ......................................viii LIST OF TABLES...................................................................ix LIST OF FIGURES ................................................................. xii LIST OF SYMBOLS, UNITS AND ACRONYMS ........................................xiii EXECUTIVE SUMMARY ......................................................... ES-1 1. INTRODUCTION ...........................................................1-1 2. TOXICOKINETICS ..........................................................2-1 2.1 Absorption ...........................................................2-1 2.1.1 Elemental Mercury ..............................................2-1 2.1.2 Inorganic Mercury ..............................................2-2 2.1.3 Methylmercury .................................................2-3 2.2 Distribution ..........................................................2-4 2.2.1 Elemental Mercury ..............................................2-4 2.2.2 Inorganic Mercury ..............................................2-4 2.2.3 Methylmercury .................................................2-5 2.3 Metabolism ..........................................................2-6 2.3.1 Elemental Mercury ..............................................2-6 2.3.2 Inorganic Mercury ..............................................2-6 2.3.3 Methylmercury .................................................2-6 2.4 Excretion ............................................................2-7 2.4.1 Elemental Mercury ..............................................2-7 2.4.2 Inorganic Mercury ..............................................2-8 2.4.3 Methylmercury .................................................2-8 2.5 Biological Monitoring ..................................................2-9 2.5.1 Elemental Mercury ..............................................2-9 2.5.2 Inorganic Mercury .............................................2-11 2.5.3 Methylmercury ................................................2-11 2.5.4 Methods of Analysis for Measuring Mercury in Biological Samples ......2-12 2.6 Studies on Pharmacokinetic Models ......................................2-12 2.6.1 Introduction ..................................................2-12 2.6.2 Inorganic mercury .............................................2-13 2.6.3 Methylmercury ................................................2-13 2.6.4 Discussion ...................................................2-15 3. BIOLOGICAL EFFECTS .....................................................3-1 3.1 Elemental Mercury ....................................................3-1 3.1.1 Critical Noncancer Data ..........................................3-1 3.1.2 Cancer Data ...................................................3-5 3.1.3 Other Data ....................................................3-9 i TABLE OF CONTENTS (continued) Page 3.2 Inorganic Mercury ....................................................3-35 3.2.1 Critical Noncancer Data .........................................3-35 3.2.2 Cancer Data ..................................................3-39 3.2.3 Other Data ...................................................3-43 3.3 Methylmercury ......................................................3-59 3.3.1 Critical Noncancer Data .........................................3-59 3.3.2 Cancer Data ..................................................3-66 3.3.3 Other Data ...................................................3-73 4. SUSCEPTIBLE POPULATIONS ...............................................4-1 5. INTERACTIONS ............................................................5-1 6. HAZARD IDENTIFICATION AND DOSE-RESPONSE ASSESSMENT ...............6-1 6.1 Background ..........................................................6-1 6.1.1 Hazard Identification ............................................6-1 6.1.2 Dose-response Assessment .......................................6-4 6.2 Hazard Identification for Mercury .........................................6-7 6.2.1 Developmental Effects ...........................................6-8 6.2.2 Germ Cell Mutagenicity .........................................6-11 6.2.3 Carcinogenic Effects ...........................................6-13 6.3 Dose-Response Assessment For Mercury ..................................6-16 6.3.1 Systemic Noncancer Effects ......................................6-16 6.3.2 Developmental Effects ..........................................6-54 6.3.3 Germ Cell Mutagenicity .........................................6-55 6.3.4 Carcinogenic Effects ...........................................6-55 6.4 Risk Assessments Done By Other Groups .................................6-56 6.4.1 Food and Drug Administration ....................................6-56 6.4.2 ATSDR ......................................................6-57 6.4.3 Department of Energy ..........................................6-57 6.4.4 National Institute of Environmental Health Sciences (NIEHS) ...........6-58 6.4.5 Department of Labor ...........................................6-58 6.4.6 Various States .................................................6-58 6.4.7 World Health Organization ......................................6-58 6.4.8 ACGIH ......................................................6-59 7. ONGOING RESEARCH AND RESEARCH NEEDS ...............................7-1 7.1 Ongoing Research .....................................................7-1 7.2 Research Needs .......................................................7-3 8. REFERENCES ..............................................................8-1 ii TABLE OF CONTENTS (continued) Page APPENDIX A DOSE CONVERSIONS ............................................... A-1 APPENDIX B SUMMARIES FOR THE INTEGRATED RISK INFORMATION SYSTEM (IRIS) ....................................... B-1 APPENDIX C ATTENDEES OF U.S. EPA PEER REVIEW WORKSHOP ON MERCURY ISSUES .............................................. C-1 APPENDIX D UNCERTAINTY ANALYSIS OF THE METHYLMERCURY RfD ............ D-1 iii U.S. EPA AUTHORS Principal Authors: Beth Hassett-Sipple Rita Schoeny, Ph.D. Office of Air Quality Office of Water Planning and Standards Washington, DC Research Triangle Park, NC Jeff Swartout National Center for Environmental Assessment-Cincinnati Office of Research and Development Cincinnati, OH Contributing Authors: Kathryn R. Mahaffey, Ph.D. National Center for Environmental Assessment-Washington Office of Research and Development Washington, DC Glenn E. Rice National Center for Environmental Assessment-Cincinnati Office of Research and Development Cincinnati, OH iv SCIENTIFIC PEER REVIEWERS Dr. William J. Adams* U.S. Department of Energy Kennecott Utah Corporation Policy Office, Washington D.C. Dr. Brian J. Allee Dr. Rick Canady Harza Northwest, Incorporated Agency for Toxic Substances and Disease Registry Dr. Thomas D. Atkeson Florida Department of Environmental Dr. Rufus Chaney Protection U.S. Department of Agriculture Dr. Donald G. Barnes* Dr. Joan Daisey* U.S. EPA Science Advisory Board Lawrence Berkeley National Laboratory Dr. Steven M. Bartell Dr. John A. Dellinger* SENES Oak Ridge, Inc. Medical College of Wisconsin Dr. David Bellinger* Dr. Kim N. Dietrich* Children’s Hospital, Boston University of Cincinnati Dr. Nicolas Bloom* Dr. Tim Eder Frontier Geosciences, Inc. Great Lakes Natural Resource Center National Wildlife Federation for the Dr. Mike Bolger States of Michigan and Ohio U.S. Food and Drug Administration Dr. Lawrence J. Fischer* Dr. Peter Botros Michigan State University U.S. Department of Energy Federal Energy Technology Center Dr. William F. Fitzgerald University of Connecticut Thomas D. Brown Avery Point U.S. Department of Energy Federal Energy Technology Center A. Robert Flaak* U.S. EPA Science Advisory Board Dr. Dallas Burtraw* Resources for the Future Dr. Bruce A. Fowler* University of Maryland at Baltimore Dr. Thomas Burbacher* University of Washington Dr. Katherine Flegal Seattle National Center for Health Statistics Dr. James P. Butler Dr. Steven G. Gilbert* University of Chicago Biosupport, Inc. Argonne National Laboratory Dr. Cynthia C. Gilmour* Elizabeth Campbell The Academy of Natural Sciences v SCIENTIFIC PEER REVIEWERS (continued) Dr. Robert Goyer Dr. Genevieve M. Matanoski* National Institute of Environmental Health The Johns Hopkins University Sciences Dr. Thomas McKone* Dr. George Gray University of California Harvard School of Public Health Berkeley Dr. Terry Haines Dr. Malcolm Meaburn National Biological Service National Oceanic and Atmospheric Administration Dr. Gary Heinz* U.S. Department of Commerce Patuxent Wildlife Research Center Dr. Michael W. Meyer* Joann L. Held Wisconsin Department of Natural Resources New Jersey Department of Environmental Protection & Energy Dr. Maria Morandi* University of Texas Science Center